GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bukwang Pharmaceutical Co Ltd (XKRX:003000) » Definitions » Stock Based Compensation

Bukwang Pharmaceutical Co (XKRX:003000) Stock Based Compensation : ₩0 Mil (TTM As of Sep. 2024)


View and export this data going back to 1988. Start your Free Trial

What is Bukwang Pharmaceutical Co Stock Based Compensation?

Bukwang Pharmaceutical Co's Stock Based Compensation for the three months ended in Sep. 2024 was ₩0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Sep. 2024 was ₩0 Mil.


Bukwang Pharmaceutical Co Stock Based Compensation Historical Data

The historical data trend for Bukwang Pharmaceutical Co's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bukwang Pharmaceutical Co Stock Based Compensation Chart

Bukwang Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 348.34 3,225.74 3.41 44.33 147.49

Bukwang Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Bukwang Pharmaceutical Co Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.


Bukwang Pharmaceutical Co Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Bukwang Pharmaceutical Co's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Bukwang Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
398-1 Daebang-Dong, Dongjak-Gu, Seoul, KOR
Bukwang Pharmaceutical Co Ltd manufactures and markets medicines for diabetes, hepatitis B, anticancer and psychiatry. The Company's OTC products focus on dental treatment. The company also engages in venture business and bio engineering.

Bukwang Pharmaceutical Co Headlines

No Headlines